Marcel F L De Bruyn

Title: Marcel F L De Bruyn: Innovator in Therapeutic Agents

Introduction

Marcel F L De Bruyn is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents targeting various diseases. With a total of 2 patents, his work focuses on innovative compounds that can potentially improve health outcomes for patients suffering from a range of conditions.

Latest Patents

De Bruyn's latest patents include pyrrolopyridine derivatives substituted with a cyclic amino group. This invention aims to provide an antagonist against CRF receptors, which can be effective as a therapeutic or prophylactic agent for diseases such as depression, anxiety, Alzheimer's disease, and more. Another significant patent involves pyrrolo[2,3-d]pyrimidine derivatives, which also target CRF receptors and address similar health issues. Both inventions demonstrate a high affinity for CRF receptors, showcasing their potential in treating various disorders.

Career Highlights

Marcel F L De Bruyn is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective treatments for complex health challenges.

Collaborations

Throughout his career, De Bruyn has collaborated with esteemed colleagues such as Atsuro Nakazato and Taketoshi Okubo. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Marcel F L De Bruyn stands out as an influential inventor in the pharmaceutical field, with a focus on creating innovative solutions for serious health conditions. His contributions through patents and collaborations reflect his dedication to improving patient care and advancing medical science.